Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

Oct 23, 2024  · BOSTON, Mass. and VANCOUVER, British Columbia, October 23, 2024 – Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing …


Install CouponFollow Chrome Extension   CouponFollow Extension

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 23, 2024  · BOSTON, Mass. and VANCOUVER, British Columbia, October 23, 2024 – Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing …

a9oncology.com

$175
OFF

Alpha-9 Oncology Secures $175M Series C To Drive …

4 weeks from now

Boston, MA and Vancouver, Canada, October 23, 2024 (PRNewswire) -- Alpha-9 Oncology has raised $175 million in Series C funding to advance its radiopharmaceutical pipeline for cancer …

jacobsmgt.com

$175
OFF

Alpha-9 Becomes Latest Radiopharma To Secure Funds With $175m …

4 weeks from now

Oct 24, 2024  · This latest financing comes after a flood of investment into the radiopharma arena over the last few years. Earlier this month, Aktis Oncology raised $175m to support the …

pharmaceutical-technology.com

$175
OFF

Alpha-9 Oncology Raises $175M In Series C Financing

4 weeks from now

Oct 25, 2024  · Boston-based Alpha-9 will use the funds to support human studies for its clinical-stage radiopharmaceutical assets and to ready discovery-stage assets for the clinic. The firm …

precisionmedicineonline.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 24, 2024  · BOSTON and VANCOUVER, BC, Oct. 23, 2024 /PRNewswire/ -- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing …

biospace.com

$175
OFF

Our Investment In Alpha-9 Oncology - Generalcatalyst.com

4 weeks from now

Oct 23, 2024  · Today, we are excited to announce our investment in Alpha-9 Oncology’s $175M Series C funding round. Radiopharmaceuticals have the potential to harness the power of …

generalcatalyst.com

$175
OFF

Radiopharma Startup Alpha-9 Nets $175M Series C

4 weeks from now

Oct 24, 2024  · In the latest deal for the red-hot radiopharmaceutical field, Alpha-9 Oncology announced an oversubscribed $175 million series C financing to support advancement of its …

insideprecisionmedicine.com

$175
OFF

Alpha-9 Oncology Secures $175M In Oversubscribed Series C …

4 weeks from now

Nov 1, 2024  · Alpha-9 Oncology Inc., a clinical stage company focused on developing radiopharmaceuticals to enhance cancer treatment, has announced the successful closing of …

patsnap.com

$175
OFF

Radiopharmaceuticals | Cancer Therapy | News - Alpha-9 Oncology

4 weeks from now

Jan 8, 2024  · Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals. BOSTON, Mass. and …

a9oncology.com

$175
OFF

Alpha-9 Oncology Secures $175 Million In Oversubscribed Series C …

4 weeks from now

Oct 24, 2024  · Alpha-9 Oncology Inc, a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, announced an …

readmagazine.com

$175
OFF

Alpha-9 Oncology Nabs $175m Series C - Venturecapitaljournal.com

4 weeks from now

Oct 23, 2024  · Also, the Series C will fund expanded R&D capabilities and continued investment in CMC and supply chain. “Alpha-9 is developing a differentiated portfolio that includes …

venturecapitaljournal.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 24, 2024  · Alpha-9 Oncology Inc. announced an oversubscribed $175 million Series C financing to support the progression of its pipeline. ... Alpha-9 has built a leading …

lifesciencesbc.ca

$175
OFF

Alpha-9's $175m Third-round Heads Latest Biotech Financings

4 weeks from now

Oct 31, 2024  · Alpha-9 Oncology raked in $175 million in a Series C led by Lightspeed Venture Partners and Ascenta Capital that will fund the transition of its pipeline of radiopharmaceutical …

pharmaphorum.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

BOSTON and VANCOUVER, BC, October 23, 2024-- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve …

vcaonline.com

$175
OFF

Radiopharma Biotech Alpha-9 Oncology Closes $175M Series C …

4 weeks from now

Oct 23, 2024  · Another private radiopharmaceutical biotech has raised big money. Alpha-9 Oncology revealed on Wednesday that it’s put together a $175 million Series C, aiming to fund …

endpts.com

FAQs about Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed … Coupon?

Who is alpha-9 oncology?

BOSTON, Mass. and VANCOUVER, British Columbia, October 23, 2024 – Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, today announced an oversubscribed $175 million Series C financing to support the progression of its pipeline. ...

What is alpha-9 oncology doing with $175m in Series C funding?

The company will use the funds to advance its pipeline of cancer-targeting preclinical candidates to the “clinic-ready” stage. Alpha-9 Oncology has raised $175m in a Series C funding round to advance its pipeline of radiopharmaceuticals. Credit: eamesBot via Shutterstock. ...

Why did alpha-9 announce a $175 million Series C financing?

BOSTON and VANCOUVER, BC, Oct. 23, 2024 /PRNewswire/ -- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, today announced an oversubscribed $175 million Series C financing to support the progression of its pipeline. ...

Why should you invest in a series C of alpha-9?

Furthermore, the Series C will fund expanded R&D capabilities and continued investment in CMC and supply chain. “Over the last few years, Alpha-9 has built a leading radiopharmaceutical company with a deep pipeline and robust infrastructure,” said Alpha-9 CEO, David Hirsch, MD, PhD. ...

Is alpha-9 a good radiopharmaceutical company?

“Over the last few years, Alpha-9 has built a leading radiopharmaceutical company with a deep pipeline and robust infrastructure,” said Alpha-9 CEO, David Hirsch, MD, PhD. “The Series C is an exciting, significant milestone for us and will greatly accelerate our growth. ...

How does alpha-9 work?

To support its endeavors, Alpha-9 has purpose-built research facilities in Vancouver, which were completed last year and have been operating at scale. These facilities help to accelerate drug development by streamlining discovery processes. Alpha-9 has also partnered with isotope suppliers and CDMOs to support its ongoing clinical trials. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension